CO2 Solutions’ innovative carbon-capture technology stands out through its ingenious use of the carbonic anhydrase (CA) enzyme. Naturally present in humans and all living organisms, CA is vital to the organic exchange of CO2 during respiration. Heads turned in 2014 when CO2 Solutions presented their high-performance industrial version of carbonic anhydrase.
The new enzyme – named 1T1 – has the catalytic properties that dramatically accelerate CO2 capture as compared to conventional technologies. It does this using simple and harmless salt solutions – another innovation – rather than the toxic solvents used by other capture technologies.
Developed with the financial assistance of the Government of Canada’s Industrial Research Assistance Program (IRAP), the 1T1 enzyme today lets CO2 Solutions offer an optimized technology that is unmatched. Whether tested in the lab or deployed in the field, the 1T1 enzyme’s longevity and catalytic performance put it in a class of its own.
In addition, CO2 Solutions was able to reduce significantly the manufacturing cost of the enzyme compared to third-party supplies, resulting in a reduction of operating costs of the technology. By enhancing the natural performance of the already impressive enzyme in its industrial lung technology, the new 1T1 enzyme has surged to the forefront. Internal development of the 1T1 enzyme also ensures that CO2 Solutions retains total control over its intellectual property, its production and applications, and has allowed the company to optimize its supply chain to the benefit of its customers.
For more information about the 1T1 enzyme and its use, contact us.